The understanding of the signal transduction cascade involving growth
factors and their receptors is one major key for diagnostic and therap
eutic improvements in human neoplasms. Using receptor autoradiography,
an inverse relationship for the incidence of somatostatin receptors (
SSR) and epidermal growth factor receptors (EGFR) was found in gliomas
[1]. In the majority of low grade gliomas, SSR were present but EGFR
were absent. In contrast, EGFR were present in most glioblastomas, but
no SSR were detected. Recently, the amplification of the EGFR gene an
d its overexpression was demonstrated to be associated with the develo
pment of glioblastomas. Several independent reports revealed that 40-5
0% of tumors show amplified EGFR [2-4]. The frequency of EGFR amplific
ation was directly associated with tumor malignancy. In addition, ampl
ified EGFR levels indicate a bad prognosis and shorter overall surviva
l [5]. Recent analysis of the EGFR gene in tumors has shown that regio
ns of this gene frequently undergo alteration. Hence, not only amplifi
cation but also mutation may be the cause of the increased malignancy
in EGFR overexpressing cells [6].